Download
s00432-021-03720-5.pdf 927,83KB
WeightNameValue
1000 Titel
  • Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
1000 Autor/in
  1. Plum, Patrick Sven |
  2. Damanakis, Alexander |
  3. Buschmann, Lisa |
  4. Ernst, Angela |
  5. Datta, Rabi Raj |
  6. Schiffmann, Lars Mortimer |
  7. Zander, Thomas |
  8. Fuchs, Hans |
  9. Chon, Seung-Hun |
  10. Alakus, Hakan |
  11. Schröder, Wolfgang |
  12. Hölscher, Arnulf Heinrich |
  13. Bruns, Christiane Josephine |
  14. Bludau, Marc |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-05
1000 Erschienen in
1000 Quellenangabe
  • 148(5):1223-1234
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00432-021-03720-5 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016042/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Patients with locally advanced esophageal or gastroesophageal adenocarcinoma benefit from multimodal therapy concepts including neoadjuvant chemoradiation (nCRT), respectively, perioperative chemotherapy (pCT). However, it remains unclear which treatment is superior concerning postoperative morbidity.!##!Methods!#!In this study, we compared the postsurgical survival (30-day/90-day/1-year mortality) (primary endpoint), treatment response, and surgical complications (secondary endpoints) of patients who either received nCRT (CROSS protocol) or pCT (FLOT protocol) due to esophageal/gastroesophageal adenocarcinoma. Between January 2013 and December 2017, 873 patients underwent Ivor Lewis esophagectomy in our high-volume center. 339 patients received nCRT and 97 underwent pCT. After 1:1 propensity score matching (matching criteria: sex, age, BMI, ASA score, and Charlson score), 97 patients per subgroup were included for analysis.!##!Results!#!After matching, tumor response (ypT/ypN) did not differ significantly between nCRT and pCT (p = 0.118, respectively, p = 0.174). Residual nodal metastasis occurred more often after pCT (p = 0.001). Postsurgical mortality was comparable within both groups. No patient died within 30 or 90 days after surgery while the 1-year survival rate was 72.2% for nCRT and 68.0% for pCT (p = 0.47). Only grade 3a complications according to Clavien-Dindo were increased after pCT (p = 0.04). There was a trend towards a higher rate of pylorospasm within the pCT group (nCRT: 23.7% versus pCT: 37.1%) (p = 0.061). Multivariate analysis identified pCT, younger age, and Charlson score as independent variables for pylorospasm.!##!Conclusion!#!Both nCRT and pCT are safe and efficient within the multimodal treatment of esophageal/gastroesophageal adenocarcinoma. We did not observe differences in postoperative morbidity. However, functional aspects such as gastric emptying might be more frequent after pCT.
1000 Sacherschließung
lokal Outcome
lokal Chemoradiation
lokal Esophageal/gastroesophageal adenocarcinoma
lokal Esophagectomy [MeSH]
lokal Original Article – Clinical Oncology
lokal Humans [MeSH]
lokal Treatment Outcome [MeSH]
lokal Retrospective Studies [MeSH]
lokal Prognosis
lokal Neoadjuvant Therapy [MeSH]
lokal Ivor Lewis esophagectomy
lokal Neoadjuvant treatment
lokal Adenocarcinoma/pathology [MeSH]
lokal Esophageal Neoplasms/surgery [MeSH]
lokal Chemotherapy
lokal Propensity Score [MeSH]
lokal Esophagogastric Junction/pathology [MeSH]
lokal Chemoradiotherapy [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-8165-4553|https://frl.publisso.de/adhoc/uri/RGFtYW5ha2lzLCBBbGV4YW5kZXI=|https://frl.publisso.de/adhoc/uri/QnVzY2htYW5uLCBMaXNh|https://frl.publisso.de/adhoc/uri/RXJuc3QsIEFuZ2VsYQ==|https://frl.publisso.de/adhoc/uri/RGF0dGEsIFJhYmkgUmFqIA==|https://frl.publisso.de/adhoc/uri/U2NoaWZmbWFubiwgTGFycyBNb3J0aW1lciA=|https://frl.publisso.de/adhoc/uri/WmFuZGVyLCBUaG9tYXM=|https://frl.publisso.de/adhoc/uri/RnVjaHMsIEhhbnM=|https://frl.publisso.de/adhoc/uri/Q2hvbiwgU2V1bmctSHVu|https://frl.publisso.de/adhoc/uri/QWxha3VzLCBIYWthbg==|https://frl.publisso.de/adhoc/uri/U2NocsO2ZGVyLCBXb2xmZ2FuZw==|https://frl.publisso.de/adhoc/uri/SMO2bHNjaGVyLCBBcm51bGYgSGVpbnJpY2g=|https://frl.publisso.de/adhoc/uri/QnJ1bnMsICBDaHJpc3RpYW5lIEpvc2VwaGluZQ==|https://frl.publisso.de/adhoc/uri/Qmx1ZGF1LCBNYXJj
1000 Hinweis
  • DeepGreen-ID: 29396907dc7f453d98e441a575bb6bc2 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6449834.rdf
1000 Erstellt am 2023-05-09T10:19:00.033+0200
1000 Erstellt von 322
1000 beschreibt frl:6449834
1000 Zuletzt bearbeitet Sat Oct 21 02:03:03 CEST 2023
1000 Objekt bearb. Sat Oct 21 02:03:03 CEST 2023
1000 Vgl. frl:6449834
1000 Oai Id
  1. oai:frl.publisso.de:frl:6449834 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source